Bioversys AG Sustainability Reports
BioVersys AG is a clinical-stage biopharmaceutical company focused on the research and development of novel antibacterial products. The company develops small molecules to address unmet medical needs in antimicrobial resistance and life-threatening bacterial infections.
Sector: Professional & technical services
Country: Switzerland
Exchange: SIX Swiss Exchange
LEI: 894500UFIGC75NPZEZ68
FIGI: BBG00X2RWGB2
1 reports from 2025 to 2025
